![Ash Jayagopal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Ash Jayagopal currently works at Opus Genetics, Inc., as Chief Scientific & Development Officer from 2024 and ASSociation For Ocular Pharmacology & Therapeutics, as President.
Dr. Jayagopal also formerly worked at Kodiak Sciences, Inc., as Executive Director-Discovery Medicine from 2019 to 2021, Opus Genetics, Inc., as Chief Scientific Officer from 2021 to 2024, F.
Hoffmann-La Roche Ltd., as Head-Molecular Pharmacology & Biomarkers from 2015 to 2019, and Vanderbilt University Medical Center, as Assistant Professor from 2008 to 2015.
Dr. Jayagopal received his Masters Business Admin degree from Kelley School of Business and doctorate degree from Vanderbilt University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OPUS GENETICS, INC. 0,62 % | 23/04/2026 | 509.233 ( 0,62 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OPUS GENETICS, INC. | Director Técnico/Científico/I+D | 14/02/2024 |
ASSociation For Ocular Pharmacology & Therapeutics
 ASSociation For Ocular Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services Association for Ocular Pharmacology & Therapeutics is a company that operates in the Membership Organizations industry. The company is located in the US. | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
Opus Genetics, Inc.
 Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Director Técnico/Científico/I+D | 01/02/2024 |
| KODIAK SCIENCES INC. | Corporate Officer/Principal | 01/01/2021 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2019 |
Vanderbilt University Medical Center
 Vanderbilt University Medical Center Medical/Nursing ServicesHealth Services Provides patient care, research and medical education and training services | Corporate Officer/Principal | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vanderbilt University Medical Center
Vanderbilt University Medical Center Medical/Nursing ServicesHealth Services Provides patient care, research and medical education and training services | Health Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
 Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kodiak Sciences, Inc.
 Kodiak Sciences, Inc. BiotechnologyHealth Technology Develops novel therapies for the treatment of retinal disease | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Opus Genetics, Inc.
Opus Genetics, Inc. BiotechnologyHealth Technology Provides clinical stage gene therapies for inherited retinal diseases | Health Technology |
ASSociation For Ocular Pharmacology & Therapeutics
ASSociation For Ocular Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services Association for Ocular Pharmacology & Therapeutics is a company that operates in the Membership Organizations industry. The company is located in the US. | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
